Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset

Recruiting now

Conditions studied: Type 1 Diabetes (T1D)

In brief

The clinical implication of this study lies in the identification of factors that may predict reduced insulin sensitivity in children and adolescents at the onset of Type 1 Diabetes and would help the physician to undertake appropriate therapy more quickly by achieving the correct therapeutic dosage, in order to achieve good metabolic compensation at an early stage and thus reduce the time (and costs) of hospitalisation.

Key facts

Study ID

NCT06717893

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

180

Starts

2020-10-09

Expected to finish

2024-12-31

Last updated by the study team

2024-12-05

Who can join

Age: any, up to 14. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≤ 14 years at the time of diagnosis of type 1 diabetes;
• Diagnosis of type 1 diabetes confirmed between January 2014 and December 2018 at the Pediatrics Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy;
• Patients with at least 1 year of follow-up after diagnosis od type 1 diabetes;
• Obtaining informed consent from parents/legal guardian of pediatric patients.

You may not qualify if…

• Patients with diabetes other that type 1;
• Patients followed at other centres at the time of onset of type 1 diabetes.

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.